Wallonia Regional Government

Total investments

5

Average round size

1M

Portfolio companies

3

Lead investments

2

Follow on index

0.20

Stages of investment
Seed
Areas of investment
BiotechnologyDrug DiscoveryInternetHealth DiagnosticsMedical DeviceLife ScienceSportsTherapeuticsTravelBiopharma

Summary

We can highlight the next thriving fund investment areas, such as Biopharma, Internet. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline A-Mansia Biotech

The typical case for the fund is to invest in rounds with 1 participant. In the next rounds fund is usually obtained by the SRIW Life Sciences, Seventure Partners, Pierre Drion.

Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2018.

Show more

Investments analytics

Analytics

Total investments
5
Lead investments
2
Follow on index
0.20
Investments by industry
  • Biotechnology (2)
  • Medical Device (2)
  • Sports (2)
  • Life Science (1)
  • Biopharma (1)
  • Show 5 more
Investments by region
  • Belgium (3)
  • United States (2)
Peak activity year
2018

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
DeciZium 01 Jan 2008 Internet, Travel Seed 1M United States, California, San Jose
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.